Allergic Rhinoconjunctivitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinoconjunctivitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-10-20Clinical Trial Update: Study for Evaluating Life Quality in Patients With Rhinoconjunctivitis
The study completed evaluating quality-of-life outcomes in patients with allergic rhinoconjunctivitis.
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: Dose-response Study With Subcutaneous Immunotherapy of an Standardized Dermatophagoides Pteronyssinus (DPT) Extract [Phase 2]
Phase 2 dose-response trial evaluating subcutaneous immunotherapy with a standardized Dermatophagoides pteronyssinus extract for allergic rh…
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense [Phase 1]
A Phase 1 trial evaluating subcutaneous immunotherapy for allergic rhinoconjunctivitis caused by Timothy grass pollen (Phleum pratense) has …
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Efficacy and Safety of Intraseasonal Specific Immunotherapy With Depiquick® Birch [Phase 3]
Phase 3 trial results update on intraseasonal specific immunotherapy with Depiquick Birch for allergic rhinoconjunctivitis has been complete…
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: MK-8237 (SCH900237) Biomarker Study in Participants With Allergic Rhinitis or Rhinoconjunctivitis (MK-8237-009) [Phase 1]
A Phase 1 biomarker study of MK-8237 (SCH900237) in participants with allergic rhinitis or rhinoconjunctivitis has completed with results po…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: Quality of Life in Allergic Rhinoconjunctivitis Patients Treated With Dialyzable Leukocyte Extracts [Phase 2]
Phase 2 trial evaluated quality of life in patients with allergic rhinoconjunctivitis treated with dialyzable leukocyte extracts. The study …
-
CLINICAL_TRIALS trial_result · 2015-04-13Clinical Trial Update: Efficacy Study of a Preseasonal Treatment With AllerT in Subjects With Birch Pollen Allergy [Phase 2]
Phase 2 efficacy results update for preseasonal AllerT treatment in individuals with birch pollen–related allergic rhinitis and rhinoconjunc…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy [Phase 2, Phase 3]
This update reports results from an open Phase 2/Phase 3 trial evaluating the tolerability of AVANZ Phleum pratense immunotherapy for allerg…
-
CLINICAL_TRIALS trial_result · 2015-01-06Clinical Trial Update: An Open Trial to Assess the Tolerability of AVANZ® Cupressus Immunotherapy [Phase 2]
Phase 2 open trial evaluating the tolerability of AVANZ Cupressus Immunotherapy for allergic rhinoconjunctivitis. The study status is comple…
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: A Safety and Immunogenicity Phase I Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid [Phase 1]
Phase 1 clinical trial evaluating the safety and immunogenicity of CryJ2-DNA-LAMP plasmid in individuals with allergic rhinoconjunctivitis; …
-
CLINICAL_TRIALS trial_result · 2014-04-30Clinical Trial Update: A Safety and Immunogenicity Phase IB Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid Assessing the Long Term Safety of Previously Treated Subjects [Phase 1]
This Phase IB trial evaluated the safety and immunogenicity of the CryJ2-DNA-LAMP plasmid in subjects with allergic rhinoconjunctivitis; the…
-
CLINICAL_TRIALS trial_result · 2014-04-11Clinical Trial Update: PURETHAL Birch RUSH Study [Phase 4]
Phase 4 clinical trial update for PURETHAL Birch RUSH evaluating treatment of allergic rhinitis and allergic rhinoconjunctivitis; the study …
-
CLINICAL_TRIALS trial_result · 2014-01-29Clinical Trial Update: Safety Clinical Trial With Depigopid 50% Grasses/50% Olea Europaea(2000DPP/ml) or Depigoid 50% Grasses/50% Parietaria Judaica(2000DPP/ml). [Phase 2]
A Phase 2 safety trial evaluating two immunotherapy formulations for grass and tree pollen allergies has completed, focusing on allergic rhi…
-
CLINICAL_TRIALS trial_result · 2014-01-27Clinical Trial Update: A Survey of Adults and Children With Allergic Rhinoconjunctivitis (MK-7243-021)
This document reports the completion and posting of results for MK-7243-021, a survey of adults and children with allergic rhinoconjunctivit…
-
CLINICAL_TRIALS trial_result · 2014-01-24Clinical Trial Update: Dose Range Finding Study With rBet v1-FV - in Adult Patients With Birch Pollen-Allergic Seasonal Rhinoconjunctivitis [Phase 2]
This document reports the completion of a Phase 2 dose-range finding study of the rBet v1-FV vaccine in adults with birch pollen–induced sea…
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: ToleroMune Grass Follow on Study
Circassia Limited reports that the ToleroMune Grass follow-on clinical trial has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Parietaria Judaica [Phase 3]
Phase 3 clinical trial evaluating subcutaneous immunotherapy for Parietaria judaica-induced allergic rhinoconjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Immunological and Histological Evaluation of Specific Immunotherapy With Recombinant Hypoallergenic Derivative [Phase 2]
A Phase 2 trial evaluating immunological and histological responses to a recombinant hypoallergenic derivative immunotherapy for allergic rh…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma [Phase 3]
Phase 3 trial evaluating safety and efficacy of recombinant Timothy grass pollen allergens adsorbed to aluminum hydroxide for allergic rhino…
-
CLINICAL_TRIALS trial_result · 2013-08-15Clinical Trial Update: ToleroMune Grass Exposure Unit Study [Phase 2]
A Phase 2 study of ToleroMune for grass pollen allergy and allergic rhinoconjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: Study of rBet v1 Tablets [Phase 2]
A Phase 2 trial of rBet v1 tablets for birch pollen–related allergic conditions has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1 [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacodynamic effects of a sublingual immunotherapy tablet containing recombinant Bet v…
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: SUBLIVAC FIX Birch Dose Tolerability/Dose Range Finding [Phase 2]
Phase 2 dose tolerability/dose-range finding study of SUBLIVAC FIX Birch has completed, evaluating tolerability across multiple doses in all…
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: PURETHAL® Mites Dose Range Finding Study in Patients With Persistent Allergic Rhinitis/Rhinoconjunctivitis [Phase 2]
Phase 2 dose-range finding study update for PURETHAL mites in patients with persistent allergic rhinitis or rhinoconjunctivitis; the trial (…
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: SUBLIVAC FIX Phleum Pratense DT/DRF [Phase 2]
Phase 2 trial of SUBLIVAC FIX Phleum Pratense DT/DRF has completed, evaluating its use for allergic rhinitis and allergic rhinoconjunctiviti…